Study gives hope of longer life to ovarian cancer suffers

A drug,codenamed CNTO328, has been developed and clincally tested that could prolong the lives of women with ovarian cancer.

The study,which involved only 18 women,of whom 8 women had their tumours stabilized or shrink. a high proportion.

The drug is an antibody that targets a molecule called interleukin 6, made by cancer cells